Gene · 191
Papers2,143
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,143
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of H19/SAHH/DNMT1 on the oxidative DNA damage related to benzo[a]pyrene exposure. | Environ Sci Pollut Res Int | 2023 | 36098921 | PubTator, text mining | PubMed |
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
| One Carbon Metabolism and S-Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes. | Livers | 2022 | 37123053 | PubTator, text mining | PubMed |
| A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. | Front Oncol | 2022 | 36713541 | PubTator, text mining | PubMed |
| Long-term prognosis of 35 patients with methionine adenosyltransferase deficiency based on newborn screening in China. | Front Cell Dev Biol | 2022 | 36704196 | PubTator, text mining | PubMed |
| A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer. | Front Pharmacol | 2022 | 36699089 | PubTator, text mining | PubMed |
| Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance. | Front Genet | 2022 | 36685962 | PubTator, text mining | PubMed |
| Recent advances in epigenetic anticancer therapeutics and future perspectives. | Front Genet | 2022 | 36685834 | PubTator, text mining | PubMed |
| Polymorphisms in COMT and OPRM1 Collectively Contribute to Chronic Shoulder Pain and Disability in South African Breast Cancer Survivors'. | Genes (Basel) | 2022 | 36672750 | PubTator, text mining | PubMed |
| Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression. | Front Immunol | 2022 | 36618403 | PubTator, text mining | PubMed |
| COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients. | Int J Mol Sci | 2022 | 36613731 | PubTator, text mining | PubMed |
| SARS-CoV-2 Infection: What Is Currently Known about Homocysteine Involvement? | Diagnostics (Basel) | 2022 | 36611302 | PubTator, text mining | PubMed |
| Abnormal methylation caused by folic acid deficiency in neural tube defects. | Open Life Sci | 2022 | 36589786 | PubTator, text mining | PubMed |
| Case Report: Adenosine kinase deficiency diagnosed 10 years after liver transplantation: Novel phenotypic insights. | Front Pediatr | 2022 | 36589157 | PubTator, text mining | PubMed |
| Plant homocysteine, a methionine precursor and plant's hallmark of metabolic disorders. | Front Plant Sci | 2022 | 36570932 | PubTator, text mining | PubMed |
| Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications. | Int J Mol Sci | 2022 | 36555400 | PubTator, text mining | PubMed |
| Methylenetetrahydrofolate Reductase C677T Gene Variant in Relation to Body Mass Index and Folate Concentration in a Polish Population. | Biomedicines | 2022 | 36551896 | PubTator, text mining | PubMed |
| One-Carbon and Polyamine Metabolism as Cancer Therapy Targets. | Biomolecules | 2022 | 36551330 | PubTator, text mining | PubMed |
| Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma. | Front Oncol | 2022 | 36544704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/191/papers?page=15